Wikidata

(Q63834620)

English

A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)

clinical trial

In more languages

Statements

title
A Placebo-controlled Phase IIa Study of Orally Administered BGC20-0134/Pleneva TM (Structured Lipid) in Patients With RRMS (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Belgium
0 references
France
0 references
Germany
0 references
Poland
0 references
Spain
0 references
start time
November 2009
0 references
end time
December 2011
0 references
number of participants
173
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63834620&oldid=1857465953"